{
  "id": 15900208,
  "title": "Samsung Biologics Posts Record Sales on U.S. Production",
  "url": "https://urgent.news/2026/10/21/samsung-biologics-posts-record-sales-on-u-s-production",
  "topic": "business",
  "section": "Business",
  "published": "2026-10-21T14:24:51.000Z",
  "source": {
    "name": "BusinessKorea",
    "slug": "businesskorea",
    "url": "https://www.businesskorea.co.kr/news/articleView.html?idxno=279377"
  },
  "original_language": "en",
  "account": null,
  "summary": "Samsung Biologics reported record sales in the third quarter of this year, with full-capacity operation of Plants 1 to 4 and U.S. production contributing to its revenue growth. The company raised its revenue growth forecast for the year from 15-20% to 20%, with consolidated revenue reaching 1.4903 trillion won, an 18% increase from the previous quarter and a 12% increase from the same period last year. While net profit grew by 9% to 391.1 billion won, the operating profit margin slowed to 43%, down 7% points from the previous year's 50%.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}